Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
30.05
+0.36 (1.21%)
At close: Mar 19, 2026, 4:00 PM EDT
30.04
-0.01 (-0.03%)
Pre-market: Mar 20, 2026, 8:37 AM EDT

Edgewise Therapeutics Stock Forecast

Stock Price Forecast

The 8 analysts that cover Edgewise Therapeutics stock have a consensus rating of "Buy" and an average price target of $37.38, which forecasts a 24.39% increase in the stock price over the next year. The lowest target is $14 and the highest is $51.

Price Target: $37.38 (+24.39%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$14$37.38$45$51
Change-53.41%+24.39%+49.75%+69.72%

Analyst Ratings

The average analyst rating for Edgewise Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingOct '25Nov '25Dec '25Jan '26Feb '26Mar '26
Strong Buy222211
Buy555555
Hold333322
Sell000000
Strong Sell000000
Total1010101088

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
JP Morgan
JP Morgan
Buy
Maintains
$34$45
BuyMaintains$34$45+49.75%Mar 17, 2026
Wedbush
Wedbush
Buy
Reiterates
$32
BuyReiterates$32+6.49%Mar 17, 2026
Evercore ISI Group
Evercore ISI Group
Buy
Maintains
$30$45
BuyMaintains$30$45+49.75%Feb 27, 2026
JP Morgan
JP Morgan
Buy
Maintains
$33$34
BuyMaintains$33$34+13.14%Nov 14, 2025
RBC Capital
RBC Capital
Buy
Maintains
$49$50
BuyMaintains$49$50+66.39%Nov 7, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
16.26M
EPS This Year
-2.15
from -1.63
EPS Next Year
-2.41
from -2.15
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
------16.26M
Revenue Growth
-------
EPS
-1.14-1.26-1.57-1.45-1.63-2.15-2.41
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1413
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027202820292030
Highn/a53.2M
Avgn/a16.3M
Lown/an/a

Revenue Growth

Revenue Growth20262027202820292030
High--
Avg--
Low--

EPS Forecast

EPS20262027202820292030
High-1.79-1.75
Avg-2.15-2.41
Low-2.43-3.26

EPS Growth

EPS Growth20262027202820292030
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.